Literature DB >> 10446741

Mirtazapine: other indications.

P Falkai1.   

Abstract

During the last decade, it became evident that antidepressants may represent a useful treatment option for a variety of primary psychiatric disorders other than depression. Improved understanding of both underlying etiology of these disorders and pharmacologic modes of action of available treatments has led to an improvement in conditions such as panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder, and premenstrual dysphoric disorder. In addition, evidence is accumulating that some new antidepressants may be of therapeutic value in treatment of some subtypes of depressive disorder previously unresponsive to treatment or difficult to treat, such as seasonal affective disorder, depression with atypical features, and recurrent brief depression. Mirtazapine is an antidepressant with mode of action different from other currently available antidepressants. A review of currently available data of mirtazapine's use in indications other than depression and in some types of depressive disorder is presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446741

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

Review 1.  Panic disorder.

Authors:  M H Rapaport; C Barrett
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 3.  Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

Authors:  G Masi; M Mucci; S Millepiedi
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.

Authors:  Chi-Un Pae; Prakash S Masand; Kathleen Peindl; Paolo Mannelli; Changsu Han; David M Marks; Ashwin A Patkar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  Drug use evaluation: A two-year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder.

Authors:  Shek Ming Leung
Journal:  Brain Behav       Date:  2021-08-01       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.